Citigroup’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$53.4K Sell
3,575
-5,001
-58% -$74.8K ﹤0.01% 3994
2025
Q1
$100K Buy
8,576
+476
+6% +$5.57K ﹤0.01% 3832
2024
Q4
$185K Buy
8,100
+638
+9% +$14.6K ﹤0.01% 3633
2024
Q3
$313K Buy
7,462
+5,187
+228% +$218K ﹤0.01% 3298
2024
Q2
$82.8K Sell
2,275
-15,246
-87% -$555K ﹤0.01% 3586
2024
Q1
$892K Buy
+17,521
New +$892K ﹤0.01% 2452
2023
Q1
Sell
-14
Closed -$137 4859
2022
Q4
$137 Sell
14
-25
-64% -$245 ﹤0.01% 4818
2022
Q3
$1K Sell
39
-23
-37% -$590 ﹤0.01% 4824
2022
Q2
$1K Sell
62
-130
-68% -$2.1K ﹤0.01% 5250
2022
Q1
$7K Sell
192
-321
-63% -$11.7K ﹤0.01% 4894
2021
Q4
$49K Buy
513
+174
+51% +$16.6K ﹤0.01% 4308
2021
Q3
$49K Sell
339
-2,622
-89% -$379K ﹤0.01% 3998
2021
Q2
$547K Sell
2,961
-1,440
-33% -$266K ﹤0.01% 3014
2021
Q1
$1.08M Buy
4,401
+4,010
+1,026% +$988K ﹤0.01% 2320
2020
Q4
$110K Buy
391
+300
+330% +$84.4K ﹤0.01% 3623
2020
Q3
$22K Sell
91
-347
-79% -$83.9K ﹤0.01% 3904
2020
Q2
$145K Buy
438
+368
+526% +$122K ﹤0.01% 3245
2020
Q1
$16K Sell
70
-247
-78% -$56.5K ﹤0.01% 4463
2019
Q4
$78K Buy
317
+67
+27% +$16.5K ﹤0.01% 3684
2019
Q3
$14K Hold
250
﹤0.01% 4431
2019
Q2
$12K Hold
250
﹤0.01% 4711
2019
Q1
$13K Buy
+250
New +$13K ﹤0.01% 4675
2017
Q4
Sell
-50
Closed -$14K 4995
2017
Q3
$14K Hold
50
﹤0.01% 4130
2017
Q2
$14K Sell
50
-24
-32% -$6.72K ﹤0.01% 4053
2017
Q1
$25K Buy
74
+2
+3% +$676 ﹤0.01% 3975
2016
Q4
$24K Sell
72
-67
-48% -$22.3K ﹤0.01% 4334
2016
Q3
$37K Buy
139
+36
+35% +$9.58K ﹤0.01% 3884
2016
Q2
$14K Sell
103
-6
-6% -$816 ﹤0.01% 4368
2016
Q1
$19K Sell
109
-9
-8% -$1.57K ﹤0.01% 4612
2015
Q4
$29K Buy
118
+116
+5,800% +$28.5K ﹤0.01% 4361
2015
Q3
$1K Sell
2
-57
-97% -$28.5K ﹤0.01% 5042
2015
Q2
$8K Sell
59
-1
-2% -$136 ﹤0.01% 4687
2015
Q1
$10K Sell
60
-15
-20% -$2.5K ﹤0.01% 4766
2014
Q4
$11K Buy
75
+50
+200% +$7.33K ﹤0.01% 4820
2014
Q3
$3K Buy
+25
New +$3K ﹤0.01% 5084